Danish pharmaceutical company ALK-Abello A/S (ALK-B.KO) said Monday it has entered into a co-promotion agreement with MSD, known as Merck in the US and Canada, for grass pollen allergy treatment Grazax in France.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
Your new post is loading...
Your new post is loading...
|
|